Detalhe da pesquisa
1.
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
J Infect Dis
; 226(3): 431-440, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584386
2.
Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection.
J Gastroenterol Hepatol
; 37(2): 371-377, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618379
3.
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals.
J Gastroenterol Hepatol
; 37(1): 190-199, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374128
4.
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
Liver Int
; 40(7): 1578-1589, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304611
5.
Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis.
Hepatol Res
; 50(2): 174-181, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31634412
6.
Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study.
Hepatol Res
; 49(6): 617-626, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849206
7.
Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis.
Hepatol Res
; 47(3): E120-E131, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27142311
8.
Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C.
Hepatol Res
; 46(3): E174-80, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26189962
9.
Portal Vein Thrombosis Repeatedly Observed in a Cirrhotic Patient with Antiphospholipid Antibody Syndrome.
Fukuoka Igaku Zasshi
; 107(10): 185-90, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29227068
10.
Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
J Gastroenterol Hepatol
; 30(12): 1759-67, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095167
11.
Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C.
J Gastroenterol Hepatol
; 30(8): 1309-16, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25777545
12.
Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.
J Gastroenterol Hepatol
; 29(9): 1728-35, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731162
13.
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.
J Hepatol
; 59(2): 205-12, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23542346
14.
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study.
J Hepatol
; 58(3): 495-501, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23099187
15.
Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy.
J Hepatol
; 59(4): 667-74, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23707372
16.
Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B.
Gut
; 61(5): 765-73, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22068163
17.
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
J Gastroenterol Hepatol
; 27(7): 1233-40, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22098185
18.
An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin.
J Infect Chemother
; 18(5): 689-97, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22450877
19.
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study.
Aliment Pharmacol Ther
; 56(4): 713-722, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35735794
20.
Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study.
Hepatol Int
; 16(2): 282-293, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075593